01 4Teflaro
Main Therapeutic Indication : Dermatology
Currency : USD
2017 Revenue in Millions : 122
2016 Revenue in Millions : 134
Growth (%) : -9
Main Therapeutic Indication : Dermatology
Currency : USD
2018 Revenue in Millions : 128
2017 Revenue in Millions : 122
Growth (%) : 5%
Main Therapeutic Indication : Dermatology
Currency : USD
2016 Revenue in Millions : 134
2015 Revenue in Millions : 138
Growth (%) : -3
Main Therapeutic Indication : Dermatology
Currency : USD
2019 Revenue in Millions : 153
2018 Revenue in Millions : 128
Growth (%) : 19
LOOKING FOR A SUPPLIER?